FEATURED COMPANIES
- Abbott Laboratories
- B. Braun Melsungen AG
- Bahrain Pharma
- Bionova Lifesciences
- Curtis Health Caps SP
- Danone S.A.
Enteral nutrition is defined as a method of feeding which uses the gastrointestinal (GI) tract to deliver part or all of an individual’s caloric requirements. Further, enteral nutrition includes a normal diet, use of liquid or powdered supplements, as well as tube feeding. This nutrition is required for the individuals suffering from malnutrition, cancer, diabetes, gastrointestinal disorders, and other complications. In addition, enteral nutrition can be used for the patients with nutritional deficits.
Market Drivers
The increase in prevalence of chronic diseases such as kidney disease, diabetes, and malnutrition is expected to propel the global enteral nutrition market growth over the forecast period. For instance, as per the information provided by the International Diabetes Federation (IDF), in 2019, around 483 million adults worldwide, in the age group of 20-79 had diabetes which is expected to reach around 700 million by 2045, resulting in 51.2% increase from 2019 and 2045. Also, as per the report published by Cancer Research UK, in 2018, over 17 million new cancer cases were diagnosed in the year 2018 and around 9.6 million deaths occurred because of cancer in 2018.
Furthermore, the increase in preterm births is one of the prominent factors boosting the demand for enteral feeding to meet the nutritional requirements of new-borns. Moreover, the increase in launch of new products will positively influence the market growth. For instance, in 2020, Victus, Inc. had launched ABINTRA Care which is specialized nutrition, helps to improve immune system.
Market Restraints
Side effects and complications caused by enteral feedings are the major restraining factors which expected to hamper the growth of global enteral nutrition market growth. For instance, if a child has gastroesophageal reflux, aggressive enteral feeding may lead the risk of aspiration or vomiting. Other physical disadvantages such as diarrhea, skin breakdown, or anatomic disruption.
Impact of COVID-19 on Market
The growing COVID-19 pandemic will significantly drive the growth of global enteral nutrition market growth. Due to the increase in demand for enteral nutritional products, as nutrition therapy is recommended to patients suffering from COVID-19 infection.
Market Segmentation
On the basis of Protein Composition, market is segmented into Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient, and Others. In terms of protein composition, the standard protein diet segment accounted for the maximum number of revenue shares of the global enteral nutrition market in the year 2020, due to the increase in demand for enteral nutrition for COVID-19 patients. Based on the form, market is segmented into Liquid, and Powder. Further, market is segmented into distribution channel such as Hospital Pharmacies, Retail Pharmacies, and E-commerce. The increase in awareness regarding enteral nutrition among hospitalized patients as well as the increase in government intervention for educating the patient population with regards to the utilization of enteral feeding pumps or systems are some of the other driving factors expected support the growth of enteral nutrition market.
Regional Analysis
The Global Enteral Nutrition Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North America dominated the enteral nutrition market and accounted for the largest revenue share, due to the growing burden of chronic diseases such as diabetes, cancer, and other neurological conditions. Further, the APAC is expected to exhibit lucrative growth over the forecast period. Due to the growing incidence of preterm births is one of the major driving factors which propel the regional demand. For instance, as per the WHO China, India, Nigeria, Pakistan, and Indonesia are among the top five countries with the largest number of preterm births.
Key Players
Major players operating in the global enteral nutrition market include Nestle S.A., Abbott Laboratories, Danone S.A., B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Bahrain Pharma, Bionova Lifesciences, Victus Inc., Curtis Health Caps SP, Johnson & Company, LLC, etc.
Market Taxonomy
By Protein Composition
By Form
By Distribution Channel
By Region
Key Questions Addressed by the Report
Market Drivers
The increase in prevalence of chronic diseases such as kidney disease, diabetes, and malnutrition is expected to propel the global enteral nutrition market growth over the forecast period. For instance, as per the information provided by the International Diabetes Federation (IDF), in 2019, around 483 million adults worldwide, in the age group of 20-79 had diabetes which is expected to reach around 700 million by 2045, resulting in 51.2% increase from 2019 and 2045. Also, as per the report published by Cancer Research UK, in 2018, over 17 million new cancer cases were diagnosed in the year 2018 and around 9.6 million deaths occurred because of cancer in 2018.
Furthermore, the increase in preterm births is one of the prominent factors boosting the demand for enteral feeding to meet the nutritional requirements of new-borns. Moreover, the increase in launch of new products will positively influence the market growth. For instance, in 2020, Victus, Inc. had launched ABINTRA Care which is specialized nutrition, helps to improve immune system.
Market Restraints
Side effects and complications caused by enteral feedings are the major restraining factors which expected to hamper the growth of global enteral nutrition market growth. For instance, if a child has gastroesophageal reflux, aggressive enteral feeding may lead the risk of aspiration or vomiting. Other physical disadvantages such as diarrhea, skin breakdown, or anatomic disruption.
Impact of COVID-19 on Market
The growing COVID-19 pandemic will significantly drive the growth of global enteral nutrition market growth. Due to the increase in demand for enteral nutritional products, as nutrition therapy is recommended to patients suffering from COVID-19 infection.
Market Segmentation
On the basis of Protein Composition, market is segmented into Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient, and Others. In terms of protein composition, the standard protein diet segment accounted for the maximum number of revenue shares of the global enteral nutrition market in the year 2020, due to the increase in demand for enteral nutrition for COVID-19 patients. Based on the form, market is segmented into Liquid, and Powder. Further, market is segmented into distribution channel such as Hospital Pharmacies, Retail Pharmacies, and E-commerce. The increase in awareness regarding enteral nutrition among hospitalized patients as well as the increase in government intervention for educating the patient population with regards to the utilization of enteral feeding pumps or systems are some of the other driving factors expected support the growth of enteral nutrition market.
Regional Analysis
The Global Enteral Nutrition Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North America dominated the enteral nutrition market and accounted for the largest revenue share, due to the growing burden of chronic diseases such as diabetes, cancer, and other neurological conditions. Further, the APAC is expected to exhibit lucrative growth over the forecast period. Due to the growing incidence of preterm births is one of the major driving factors which propel the regional demand. For instance, as per the WHO China, India, Nigeria, Pakistan, and Indonesia are among the top five countries with the largest number of preterm births.
Key Players
Major players operating in the global enteral nutrition market include Nestle S.A., Abbott Laboratories, Danone S.A., B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Bahrain Pharma, Bionova Lifesciences, Victus Inc., Curtis Health Caps SP, Johnson & Company, LLC, etc.
Market Taxonomy
By Protein Composition
- Standard Protein Diet
- High Protein Supplement
- Protein for Diabetes Care Patient
- Others
By Form
- Liquid
- Powder
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Enteral Nutrition Market?
- What will be the growth rate from 2019 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
Frequently Asked Questions about the Global Enteral Nutrition Market
What is the estimated value of the Global Enteral Nutrition Market?
What is the growth rate of the Global Enteral Nutrition Market?
What is the forecasted size of the Global Enteral Nutrition Market?
Who are the key companies in the Global Enteral Nutrition Market?
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Laboratories
- B. Braun Melsungen AG
- Bahrain Pharma
- Bionova Lifesciences
- Curtis Health Caps SP
- Danone S.A.
1 Introduction
2 Research Methodology
4 Global Enteral Nutrition Market Outlook
5 Global Enteral Nutrition Market, By Protein Composition
6 Global Enteral Nutrition Market, By Form
7 Global Enteral Nutrition Market, By Distribution Channel
8 Global Enteral Nutrition Market, By Region
9 North America Enteral Nutrition Market Analysis and Forecast (2020-2027)
10 EuropeEnteral Nutrition Market Analysis and Forecast (2020-2027)
11 Asia Pacific Enteral Nutrition Market Analysis and Forecast (2020-2027)
12 Latin America Enteral Nutrition Market Analysis and Forecast (2020-2027)
13 Middle East Enteral Nutrition Market Analysis and Forecast (2020-2027)
14 Competitive Analysis
15 Company Profiles
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- Nestle S.A.
- Abbott Laboratories
- Danone S.A.
- B. Braun Melsungen AG
- Otsuka Pharmaceutical Co. Ltd
- Bahrain Pharma
- Bionova Lifesciences
- Victus Inc.
- Curtis Health Caps SP
- Johnson & Company LLC
- etc
Note: Product cover images may vary from those shown